James M. Frates, CFO: Amylyx Pharmaceuticals AMLX Sell · Filed 25/10/02

Trade details

Type: Insider sale
Amount: $154,674.7
Shares · price: 10,558 sh · $14.65 a share
Held after: 280,430 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: James M. FratesCFO
Trade date: 25/09/30
Filed: 25/10/02
Days to filing: 2 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

James M. Frates's recent trades

James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$349.8K
10,810 sh
$349.8K
Filed 09/11
Traded 09/10
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$114.8K
7,909 sh
$114.8K
Filed 03/04
Traded 03/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$114.9K
7,909 sh
$114.9K
Filed 03/02
Traded 03/02
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/04
Traded 02/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/02
Traded 02/02